GlassScriptPhysician profile
Elizabeth S Petrides
NPI 1649343567
$1,263.62
in general payments reported to CMS, 2019-2025
11 companies · $596 in 2025
The $596 reported for 2025 was more than what 90% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $159 · 2023: $136 · 2024: $235 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $415.07 | 2021-2025 | Sapien 3 Ultra Resilia |
| Atricure, INC. | $353.51 | 2022-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Medtronic, INC. | $152.35 | 2025 | Corevalve Evolut R |
| Silk Road Medical, INC. | $87.55 | 2022 | |
| Abiomed | $83.32 | 2025 | |
| Smith+Nephew, INC. | $75.70 | 2024-2025 | Pico 14 |
| Pfizer INC. | $32.00 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $25.99 | 2024 | Sternalock Blu System |
| Grifols USA, LLC | $20.42 | 2025 | Thrombate III |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.93 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.78 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Petrides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.